Kera Capital Partners »

Regeneron Pharmaceuticals shares owned by Kera Capital Partners

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Kera Capital Partners from 13F filings

Historical chart of Kera Capital Partners investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Kera Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Kera Capital Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $281k 499 562.27

More positions owned by Kera Capital Partners

NVIDIA Corporation (NVDA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Capital Group Growth Etf Shs Creation Uni (CGGR)
Goldman Sachs Etf Tr Activebeta Int (GSIE)
Capital Group Dividend Value Shs Creation Uni (CGDV)
Robinhood Mkts Com Cl A (HOOD)
Coinbase Global Com Cl A (COIN)
Corning Incorporated (GLW)
Vertiv Holdings Com Cl A (VRT)
Intel Corporation (INTC)
Arista Networks Com Shs (ANET)
Broadcom (AVGO)
Amazon (AMZN)
Nu Hldgs Ord Shs Cl A (NU)

View all positions for Kera Capital Partners

Top funds holding Regeneron Pharmaceuticals

Vanguard Group
BlackRock
State Street Corporation
Dodge & Cox
Jpmorgan Chase & Co
Geode Capital Management
Franklin Resources
Capital World Investors
Loomis, Sayles and
FMR
Invesco
Susquehanna International
Morgan Stanley
Goldman Sachs Group
Nuveen

View all funds holding Regeneron Pharmaceuticals